News

March 31, 2020

Precision Biomonitoring Receives Letter of Intent from the Government of Canada for its Testing Capabilities in Response to COVID-19

Point-of-need COVID-10 test awaiting approval by Health Canada 

GUELPH, Ontario and MISSISSAUGA, Ontario, March 31, 2020 – Precision Biomonitoring, an industry leader in developing environmental DNA (eDNA) tools to detect organisms at the point-of-need in 60 minutes, announces that it has been selected by the Government of Canada through a Letter of Intent with Public Services and Procurement Canada (PSPC) and Innovation, Science and Economic Development Canada (ISED) for its point-of-need SARS-CoV-2 Go-Strips test and battery-operated instrument in response to COVID-19. Precision Biomonitoring is one of the first ten companies to receive a Letter of Intent in the COVID-19 procurement space.

SARS-CoV-2 Go-Strips detect the RNA of severe acute respiratory syndrome, COVID-19. The COVID-19 RNA targets are multiplexed together with Biomeme’s RNA positive control, which is an RNA extraction and RT-PCR control, allowing results to be obtained onsite in 60 minutes. Early identification and diagnosis of COVID-19 is crucial to ensure a rapid response, thus mitigating the possible additional negative consequences of the virus. Weighing only 1.2 kg and battery-operated, Precision Biomonitoring’s mobile solution is ideal for all point-of-need locations where screening is needed for vulnerable populations such as assessment centers, long-term care homes, ships, airports, borders and more distant regions and remote areas. The test is currently awaiting Health Canada approval.

“We are immensely proud to have been selected as an early partner by our Federal Government,” says Dr. Mario Thomas, CEO, Precision Biomonitoring. “Precision Biomonitoring’s innovative point-of-need testing device addresses the call made by the Government of Canada’s Plan to Mobilize Industry to fight COVID-19. By pivoting and building from our experience in the sensitive area of food and water safety we are now looking forward to working with the Canadian health care community during this unprecedented time.”

With the ability to administer nine tests per hour at the point-of-need in 60 minutes, the SARS-CoV-2 Go-Strips will help contribute to the call from all levels of government to increase testing capacity for COVID-19. 

About Precision Biomonitoring SARS-CoV-2 Go-Strips

Precision Biomonitoring’s easy-to-use Go-Strips are a mobile solution for health care providers in Ontario and across Canada. The device can be transported in a laptop-sized bag, ideal for on the spot tests, especially when results are needed now in emergency rooms and more rural and remote regions.

About Precision Biomonitoring 

Founded in 2016 by a team of scientists from the University of Guelph’s Biodiversity Institute of Ontario, Precision Biomonitoring provides TripleLock™ onsite eDNA surveillance platform solutions that give customers earlier detection of organisms for a more rapid response. Customers are any organizations that need onsite surveillance and rapid identification of any organism in any environment. The Precision Biomonitoring team is at the forefront of technological innovations in the genomics industry. Our vision is a world where we can identify any organism on the spot, in an instant, anywhere on the planet. 

Media Contact:  

Meredith Adams 

416-459-7086 

Madams@national.ca

March 20, 2020

Precision Biomonitoring Announces its Health Canada Submission for Point-of-Care SARS CoV-2 Go-Strips

Precision Biomonitoring Responds to Health Canada’s Call for COVID-19 Research and Development with Innovative Point-of-Care Testing Solution

GUELPH, Ontario and MISSISSAUGA, Ontario, March 20, 2020 – Precision Biomonitoring, an industry leader in developing environmental DNA (eDNA) tools to detect organisms, announces the submission of its point-of-care SARS-CoV-2 Go-Strips and rapid mobile detection device to Health Canada for approval and use in Canada in response to the COVID-19 virus. The submission was based on lab validation data generated  through testing viral samples and its on-going collaboration with major research institutions in Ontario and Manitoba, including with teams that recently identified and isolated the RNA of the new novel coronavirus.

Our recent collaboration with healthcare and research institutions across the country positions us well to work with the Government of Canada and healthcare decision makers to provide innovative, point-of-care testing for COVID-19 in 60 minutes,” says Dr. Mario Thomas, CEO, Precision Biomonitoring. “We are looking forward to playing our part in combatting this virus.”

A proud Canadian company, Precision Biomonitoring, recognizes the importance of working with public health officials to ensure the safety of all Canadians. “Our technologies are inspired by our ongoing pursuit for innovation, and in the face of a rapidly evolving situation such as COVID-19, that relentless commitment is all the more critical,” says Thomas. “To know that our company is working towards supporting health care professionals in enabling the diagnosis and care taking place across Canada continues to fuel our efforts. We look forward to a timely response from Health Canada.”

Precision Biomonitoring has a demonstrated track record of being agile and adjusting to the scientific and medical needs of the Canadian landscape. Its ongoing work and strong existing relationships with the Government of Canada, as well as the Canadian Food Inspection Agency in the food safety and animal health space, has provided Precision Biomonitoring with the knowledge and experience necessary to be a trusted, collaborative partner to Health Canada.

About Precision Biomonitoring

Founded in 2016 by a team of scientists from the University of Guelph’s Biodiversity Institute of Ontario, Precision Biomonitoring provides TripleLock™ onsite eDNA surveillance platform solutions that give customers earlier detection of organisms for a more rapid response. Customers are any organizations that need onsite surveillance and rapid identification of any organism in any environment. The Precision Biomonitoring team is at the forefront of technological innovations in the genomics industry. Our vision is a world where we can identify any organism on the spot, in an instant, anywhere on the planet.

Media Contact: 

Meredith Adams

416-459-7086

madams@national.ca 

July 3, 2019
Precision Biomonitoring and AgriSeq Solutions Announce Strategic Partnership in Genomics

June 18, 2019
Precision Biomonitoring and Birks Natural Heritage Consultants Announce Strategic Partnership Advancing Adoption of Environmental DNA Methods http://bit.ly/2ZxV5cN 

May 14, 2019
Precision Biomonitoring Inc. and EcoMetrix Inc. have joined forces to advance the state of basic and applied science as it relates to Environmental DNA (eDNA) tools, approaches and methodologies. http://bit.ly/2WIHb6w

May 7, 2019
Precision Biomontoring Awarded ‘Build in Canada Innovation Program’ Contract. https://bit.ly/2GkKdaY

https://www.uoguelph.ca/ib/PISCeS

October 11, 2018
Precision Biomonitoring sponsors the first National eDNA National Worshop hosted by University of Guelph on October 11-12,2018

info@precisionbiomonitoring.com
1-226-486-3252

Orchard Park – Suite #226 
5420 Highway 6 North
Guelph ON  Canada
N1H 6J2